tyrosine has been researched along with endomorphin 1 in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Blanchfield, JT; Koda, Y; Okada, Y; Shiotani, K; Toth, I; Tsuda, Y | 1 |
| Bryant, SD; Jinsmaa, Y; Lazarus, LH; Li, T; Marczak, ED; Okada, Y; Tsuda, Y | 1 |
| Brown, A; Hooley, M; Hothersall, JD; Humphreys, S; McMurray, G; Nickolls, SA; Torella, R | 1 |
3 other study(ies) available for tyrosine and endomorphin 1
| Article | Year |
|---|---|
Comparison of the in vitro apparent permeability and stability of opioid mimetic compounds with that of the native peptide.
Topics: Analgesics, Opioid; Blood-Brain Barrier; Caco-2 Cells; Chemistry, Pharmaceutical; Drug Design; Humans; Inhibitory Concentration 50; Injections, Intraventricular; Kinetics; Molecular Conformation; Oligopeptides; Peptides; Permeability; Receptors, Opioid; Tyrosine | 2007 |
[N-allyl-Dmt1]-endomorphins are micro-opioid receptor antagonists lacking inverse agonist properties.
Topics: Analgesics, Opioid; Animals; Brain; Cell Line; Cell Membrane; Cyclic AMP; Guanosine 5'-O-(3-Thiotriphosphate); Male; Mice; Oligopeptides; Protein Binding; Radioligand Assay; Receptors, Opioid, mu; Substance Withdrawal Syndrome; Tyrosine | 2007 |
Residues W320 and Y328 within the binding site of the μ-opioid receptor influence opiate ligand bias.
Topics: Analgesics, Opioid; beta-Arrestins; Binding Sites; Cyclic AMP; Diprenorphine; Enkephalin, Ala(2)-MePhe(4)-Gly(5)-; G-Protein-Coupled Receptor Kinase 2; HEK293 Cells; Humans; Models, Molecular; Mutagenesis; Mutation; Narcotic Antagonists; Oligopeptides; Receptors, Opioid, mu; Signal Transduction; Transfection; Tritium; Tryptophan; Tyrosine | 2017 |